Please assess the completion status of the following clinical trial:

Trial Title: Corticoids in Severe Community-Acquired Pneumonia (CAP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Severe community-acquired pneumonia Fine V~* CRP \>=15 mg/100 mL~Exclusion Criteria:~* Major contraindications for corticosteroids, such as uncontrolled diabetes, immunosuppression~* Previous glucocorticoid treatment during the previous month~* Documented extrapulmonary infection~* Previous hospitalization in the previous month

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- methylprednisolone (Type: EXPERIMENTAL): methylprednisolone 0.5 mg/kg body weight every 12 h for 5 days
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).